Condensed Statement of Cash Flows (Unaudited) - USD ($)	5 Months Ended	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2019
Cash flows from operating activities:
Net income (loss)	$ (40,616)	$ 267,638
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on securities held in Trust Account		(838,498)
Unrealized gain on securities held in Trust Account		(7,676)
Changes in operating assets and liabilities:
Prepaid expenses		(25,842)
Accounts payable and accrued expenses		46,229
Net cash used in operating activities	(40,616)	(558,149)
Cash flows from investing activities:
Investment of cash in Trust Account		(57,500,000)
Net cash used in investing activities		(57,500,000)
Cash flows from financing activities:
Proceeds from sale of Units, net of underwriting discount paid		55,775,000
Proceeds from sale of Private Units		2,700,000
Proceeds from issuance of ordinary shares to initial shareholders	25,100
Proceeds from sale of unit purchase option		100
Proceeds from promissory note - related party	178,205	100,831
Repayment of promissory note - related party		(50,831)
Advances from related party		12,821
Payment of offering costs	(120,621)	(363,579)
Net cash provided by financing activities	82,684	58,174,342
Net change in cash	42,068	116,193
Cash at beginning of period		52,937
Cash at end of period	42,068	169,130
Non-cash investing and financing activities:
Initial classification of ordinary shares subject to possible redemption		50,740,740
Change in value of ordinary shares subject to possible redemption		276,028
Deferred underwriting fee payable		2,012,500
Conversion of advances and short-term promissory notes to long-term promissory notes		$ 415,641